Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | - | 4.0 |
Min SIP Amount | ₹100 | ₹500 |
Expense Ratio | 1.82 | 1.73 |
NAV | ₹14.92 | ₹74.88 |
Fund Started | 11 Jan 2023 | 21 Oct 2008 |
Fund Size | ₹4073.54 Cr | ₹5659.43 Cr |
Exit Load | Exit load of 1%, if redeemed within 365 days. | Exit load of 1%, if redeemed within 30 days. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 9.19% | 7.38% |
3 Year | - | 22.32% |
5 Year | - | 17.03% |
1 Year
3 Year
5 Year
Equity | 64.41% | 61.50% |
Cash | 23.01% | 21.96% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
Reliance Industries Ltd. | 4.04% |
HDFC Bank Ltd. | 3.50% |
ICICI Bank Ltd. | 3.35% |
Kotak Mahindra Bank Ltd. | 2.90% |
Bharti Airtel Ltd. | 2.56% |
Infosys Ltd. | 2.56% |
Larsen & Toubro Ltd. | 1.93% |
Bajaj Finance Ltd. | 1.73% |
Coforge Ltd. | 1.66% |
Mahindra & Mahindra Ltd. | 1.65% |
Name | Assets |
---|---|
ICICI Bank Ltd. | 4.02% |
Bharti Airtel Ltd. | 2.83% |
HDFC Bank Ltd. | 2.66% |
Infosys Ltd. | 2.62% |
ITC Ltd. | 2.36% |
Tata Consultancy Services Ltd. | 2.36% |
HCL Technologies Ltd. | 2.35% |
Bajaj Finserv Ltd. | 2.09% |
Reliance Industries Ltd. | 2.03% |
Sun Pharmaceutical Industries Ltd. | 1.68% |
Name | Dhaval Joshi | Sunil Madhukar Patil |
Start Date | 21 Nov 2022 | 12 Dec 2022 |
Name
Start Date
Description | The Scheme seeks to provide long term capital appreciation by investing across asset classes like Equity, Debt, Commodities, & units of REITs & InvITs. | The Scheme seeks to achieve long term capital appreciation by investing predominantly in a diversified portfolio of equity and equity related instruments. The fund also invests in debt and money market instruments with a view to generate regular income. The fund also invests in Gold ETFs. The portfolio allocation is managed dynamically. |
Launch Date | 11 Jan 2023 | 21 Oct 2008 |
Description
Launch Date